Page last updated: 2024-08-26

deoxypyridinoline and Endocrine System Diseases

deoxypyridinoline has been researched along with Endocrine System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carnevale, V; Chiodini, I; D'Aloiso, L; Di Giorgio, A; Dicembrino, F; Frusciante, V; Fusilli, S; Garrubba, M; Minisola, S; Modoni, S; Scillitani, A; Torlontano, M; Trischitta, V1

Other Studies

1 other study(ies) available for deoxypyridinoline and Endocrine System Diseases

ArticleYear
Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:10

    Topics: Acromegaly; Adult; Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Remodeling; Cushing Syndrome; Endocrine System Diseases; Female; Humans; Hyperparathyroidism; Middle Aged; Osteocalcin; Radiopharmaceuticals; Regression Analysis; Technetium Tc 99m Medronate; Thyrotoxicosis

2002